WELCH JAMES H 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 7, 2013
Insider Transaction Report
Form 4
WELCH JAMES H
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-02-05+141,775→ 141,775 totalExercise: $5.31From: 2014-02-05Exp: 2023-02-04→ Common Stock (141,775 underlying)
Footnotes (3)
- [F1]Issued pursuant to the 2011 Equity Incentive Plan.
- [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 5, 2013) and the remaining shares subject to the stock option vest on an equal monthly basis over the following 36 months.
- [F3]The shares have double-trigger acceleration on a change of control.